Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Taro: Fiscal Q3 Earnings Snapshot AP - Thu Jan 25, 4:14PM CST

Taro: Fiscal Q3 Earnings Snapshot

TARO : 42.25 (+0.14%)
Taro: Fiscal Q2 Earnings Snapshot AP - Thu Oct 26, 2023

Taro: Fiscal Q2 Earnings Snapshot

TARO : 42.25 (+0.14%)
Taro: Fiscal Q1 Earnings Snapshot AP - Thu Jul 27, 2023

Taro: Fiscal Q1 Earnings Snapshot

TARO : 42.25 (+0.14%)
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro PR Newswire - Wed Jul 19, 2023

/PRNewswire/ -- As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun...

TARO : 42.25 (+0.14%)
Why Shares of Taro Pharmaceutical Are Rising Tuesday Motley Fool - Tue May 30, 2023

The company is mulling a buyout offer from Sun Pharmaceutical.

TARO : 42.25 (+0.14%)
Taro: Fiscal Q4 Earnings Snapshot AP - Tue May 23, 2023

Taro: Fiscal Q4 Earnings Snapshot

TARO : 42.25 (+0.14%)
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates Zacks - Tue Jan 24, 2023

Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TARO : 42.25 (+0.14%)
CTLT : 55.48 (-0.57%)
Taro Provides Results for December 31, 2022 Business Wire - Tue Jan 24, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022.

TARO : 42.25 (+0.14%)
Taro to Release Third Quarter Results on January 24, 2023 Business Wire - Thu Jan 19, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January...

TARO : 42.25 (+0.14%)
Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates Zacks - Thu Oct 27, 2022

Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TARO : 42.25 (+0.14%)
SCYX : 1.4400 (+2.49%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth Barchart - 4 minutes ago
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot